Total Payments
$9,032
2024 Payments
$719.75
Companies
29
Transactions
188
Medicare Patients
9,958
Medicare Billing
$825,154
Payment Breakdown by Category
Travel$5,360 (59.3%)
Food & Beverage$3,622 (40.1%)
Education$49.67 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $5,360 | 13 | 59.3% |
| Food and Beverage | $3,622 | 171 | 40.1% |
| Education | $49.67 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $5,344 | 25 | $0 (2020) |
| Abbott Laboratories | $1,361 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $427.74 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $313.62 | 20 | $0 (2024) |
| Medtronic, Inc. | $268.87 | 10 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $168.36 | 9 | $0 (2024) |
| Amgen Inc. | $153.74 | 9 | $0 (2024) |
| ABIOMED | $107.25 | 2 | $0 (2020) |
| BIOTRONIK INC. | $98.08 | 6 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $98.08 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $719.75 | 38 | Abbott Laboratories ($286.22) |
| 2023 | $507.25 | 29 | Actelion Pharmaceuticals US, Inc. ($101.76) |
| 2022 | $1,292 | 26 | Abbott Laboratories ($1,056) |
| 2021 | $263.19 | 20 | BIOTRONIK INC. ($46.11) |
| 2020 | $280.58 | 10 | Medtronic Vascular, Inc. ($108.00) |
| 2019 | $1,935 | 19 | Medtronic Vascular, Inc. ($1,786) |
| 2018 | $1,507 | 20 | Medtronic Vascular, Inc. ($1,304) |
| 2017 | $2,527 | 26 | Medtronic Vascular, Inc. ($2,146) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Structural Heart | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Structural Heart | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: Cardiovascular | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiology | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Abbott Laboratories | ID NOW INSTRUMENT (Device) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: Rapid Diagnostics | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/03/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/26/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $92.00 | General |
| Category: Structural Heart | ||||||
| 06/26/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Structural Heart | ||||||
| 06/26/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Structural Heart | ||||||
| 05/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.73 | General |
| Category: Cardiovascular | ||||||
| 05/13/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $41.82 | General |
| Category: Structural Heart | ||||||
| 04/26/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Stents | ||||||
| 04/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Not Applicable | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,874 | 2,318 | $925,649 | $204,121 |
| 2022 | 34 | 2,264 | 2,596 | $815,181 | $183,889 |
| 2021 | 32 | 2,970 | 3,761 | $1.0M | $215,003 |
| 2020 | 32 | 2,850 | 3,669 | $1.0M | $222,141 |
Total Patients
9,958
Total Services
12,344
Medicare Billing
$825,154
Procedure Codes
141
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 424 | 740 | $308,580 | $94,162 | 30.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 48 | 79 | $144,728 | $29,504 | 20.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 253 | 267 | $143,913 | $13,866 | 9.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 102 | 113 | $44,748 | $11,544 | 25.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 57 | 59 | $54,870 | $10,183 | 18.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 43 | 43 | $25,628 | $7,301 | 28.5% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 26 | 26 | $28,834 | $6,087 | 21.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 72 | 73 | $55,447 | $5,944 | 10.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 376 | 398 | $22,288 | $4,282 | 19.2% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 36 | 37 | $10,542 | $2,848 | 27.0% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 31 | 36 | $6,444 | $2,633 | 40.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 28 | 44 | $10,472 | $2,555 | 24.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 24 | 25 | $7,725 | $2,249 | 29.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 21 | 23 | $12,696 | $1,906 | 15.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 26 | 26 | $7,644 | $1,697 | 22.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 37 | $4,218 | $1,404 | 33.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 56 | 60 | $4,440 | $1,201 | 27.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 19 | 19 | $10,214 | $1,063 | 10.4% |
| 92979 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | Facility | 2023 | 13 | 16 | $1,744 | $932.80 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $4,017 | $850.72 | 21.2% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 24 | 24 | $1,776 | $484.32 | 27.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 45 | 45 | $2,070 | $472.14 | 22.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 39 | 40 | $10,400 | $392.40 | 3.8% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 29 | 29 | $1,276 | $272.92 | 21.4% |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg | Office | 2023 | 28 | 29 | $493.00 | $179.06 | 36.3% |
About Dr. Michael Ritchie, MD
Dr. Michael Ritchie, MD is a Cardiovascular Disease healthcare provider based in Great Falls, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386717437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ritchie, MD has received a total of $9,032 in payments from pharmaceutical and medical device companies, with $719.75 received in 2024. These payments were reported across 188 transactions from 29 companies. The most common payment nature is "Travel and Lodging" ($5,360).
As a Medicare-enrolled provider, Ritchie has provided services to 9,958 Medicare beneficiaries, totaling 12,344 services with total Medicare billing of $825,154. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Great Falls, MT
- Active Since 11/16/2006
- Last Updated 03/17/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1386717437
Products in Payments
- Endurant (Device) $3,079
- Advisa (Device) $2,098
- AMPLATZER AMULET (Device) $1,236
- ENTRESTO (Drug) $333.22
- ELIQUIS (Drug) $198.35
- Adapta (Device) $193.69
- CAMZYOS (Drug) $176.03
- Repatha (Biological) $139.94
- OPSUMIT (Drug) $119.81
- CoreValve Evolut (Device) $108.00
- Impella (Device) $107.25
- XARELTO (Drug) $98.08
- LEQVIO (Drug) $94.52
- Verquvo (Drug) $71.81
- Arcalyst (Drug) $67.82
- ONYX FRONTIER (Device) $62.91
- VERQUVO (Drug) $62.22
- LifeVest (Device) $60.94
- AMPLATZER (Device) $59.49
- TRELEGY ELLIPTA (Drug) $49.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Great Falls
Dr. Steven Goldberg, M.d, M.D
Cardiovascular Disease — Payments: $208,060
Cardiovascular Disease $208,060
Dr. Jorge Castriz, M.d, M.D
Cardiovascular Disease — Payments: $5,370
Cardiovascular Disease $5,370
Miroslaw Sochanski, M.d, M.D
Cardiovascular Disease — Payments: $1,849
Cardiovascular Disease $1,849
Edmund Brennan, Md, MD
Cardiovascular Disease — Payments: $1,628
Cardiovascular Disease $1,628
Eve Gerasimou, Md, MD
Cardiovascular Disease — Payments: $1,155
Cardiovascular Disease $1,155
Dr. Daniel Walker, Md, MD
Cardiovascular Disease — Payments: $15.26
Cardiovascular Disease $15.26